Ceapro Inc (CRPOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRPOF | BMY | AMGN | GILD | VRTX |
| Company | Ceapro Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.1845 | 47.39 | 273.45 | 67.47 | 402.44 |
| High | 0.1845 | 47.50 | 274.35 | 67.90 | 403.88 |
| Low | 0.1845 | 45.15 | 268.04 | 65.89 | 395.09 |
| Last | 0.1845 | 45.48 | 268.37 | 65.86 | 395.01 |
| Change | +0.0074 | -3.38 | -4.64 | -1.22 | -5.75 |
| % Change | +4.18% | -6.92% | -1.70% | -1.82% | -1.43% |
| Volume | 600 | 8,737,601 | 227,949 | 1,336,083 | 112,527 |
| 20-Day Average Volume | 24,480 | 10,908,175 | 2,067,326 | 6,147,293 | 928,609 |
| Previous Close | 0.1771 | 48.86 | 273.01 | 67.08 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1592 | 49.98 | 270.76 | 68.74 | 402.33 |
| 20-Day Raw Stochastic | 100.00% | 2.14% | 35.18% | 6.90% | 23.16% |
| 20-Day Relative Strength | 55.61% | 30.22% | 45.78% | 31.27% | 42.93% |
| Weighted Alpha | -54.40 | -32.97 | +9.74 | -21.80 | +15.01 |
| Today's Opinion | 56% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 56% Sell | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 24% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.55% since 03/26/24 | -5.70% since 04/18/24 | +2.95% since 04/18/24 | +0.44% since 04/18/24 | +1.16% since 04/18/24 |
| Low | 0.1750 on 04/03/24 | 45.35 on 04/25/24 | 260.68 on 04/19/24 | 66.16 on 04/19/24 | 391.25 on 04/19/24 |
| High | 0.1845 on 04/22/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | +14.03% since 03/08/24 | -12.83% since 03/25/24 | -3.68% since 03/25/24 | -8.45% since 03/25/24 | -4.32% since 03/25/24 |
| Low | 0.1669 on 03/26/24 | 45.35 on 04/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 0.1845 on 04/22/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +57.56% since 01/18/24 | -8.19% since 01/25/24 | -12.82% since 01/25/24 | -17.18% since 01/25/24 | -7.42% since 01/25/24 |
| Low | 0.1146 on 01/29/24 | 45.35 on 04/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 0.1845 on 04/22/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -30.40% since 10/20/23 | -19.55% since 10/25/23 | -0.61% since 10/25/23 | -15.23% since 10/25/23 | +9.65% since 10/25/23 |
| Low | 0.1146 on 01/29/24 | 45.35 on 04/25/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 0.2770 on 10/24/23 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,445 | 99,027,448 | 146,436,016 | 83,519,768 | 103,580,040 |
| Shares Outstanding, K | 78,293 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 14,490,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 3,380,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 1,950,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -780,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.53 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 11/29/23 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/23/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 9.97 | 30.13 |